CD163 and chronic myelogenous leukemia, BCR-ABL1 positive: The expression of CD163+ macrophages is distributed in released patients with CML-CP (8.73 ± 2.00)%, CML-AP (17.23 ± 3.24)%, and CML-BP groups (34.11 ± 4.95)%, respectively.